ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,533Medicare Part D Prescriptions Filled, Including Refills

Rank: 423 out of 2429

$322K Total Retail Price of All Prescriptions

Rank: 636 out of 2429

326 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 326 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 326 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,277 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 345 335 1 3
FUROSEMIDE 321 320 2 5
SIMVASTATIN 262 248 3 1
METOPROLOL TARTRATE 255 255 4 9
LISINOPRIL 234 229 5 2
METOPROLOL SUCCINATE 217 217 6 12
AMLODIPINE BESYLATE 204 202 7 4
HYDROCODONE-ACETAMINOPHEN 174 156 S3 8 6
ATENOLOL 169 169 9 15
BUMETANIDE 166 164 10 157
ATORVASTATIN CALCIUM 151 149 11 13
POTASSIUM CHLORIDE 134 132 12 14
METFORMIN HCL 133 127 13 8
DONEPEZIL HCL 123 123 14 26
HYDROCHLOROTHIAZIDE 121 117 15 10
ALENDRONATE SODIUM 120 108 16 20
ALLOPURINOL 115 115 17 33
DIOVAN 110 110 18 36
OMEPRAZOLE 110 110 18 7
LOSARTAN POTASSIUM 104 101 20 22
NAMENDA 101 101 21 35
PAROXETINE HCL 89 84 22 67
FAMOTIDINE 88 88 23 42
QUETIAPINE FUMARATE 86 86 24 77
CLOPIDOGREL 84 84 25 31
DIGOXIN 75 75 26 43
CRESTOR 71 66 27 25
LOVASTATIN 66 66 28 30
TRAZODONE HCL 63 63 29 50
PRAVASTATIN SODIUM 62 62 30 16
POLYETHYLENE GLYCOL 3350 61 61 31 56
RAMIPRIL 60 60 32 118
GLYBURIDE 58 57 R 33 64
PLAVIX 57 57 34 44
PREDNISONE 56 56 35 38
CITALOPRAM HBR 56 52 35 19
OXYCODONE-ACETAMINOPHEN 55 55 S2 37 201
CARBIDOPA-LEVODOPA 55 55 37 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 53 39 27
GABAPENTIN 53 47 40 18
MELOXICAM 52 52 41 40
CYMBALTA 51 51 42 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.